Ackerman Joel
ACKERMAN JOEL, DIR, reported a transaction classified as exercise at CHAMPIONS ONCOLOGY, INC. involving 69794.000000 shares for an estimated $111670.40. Reported holdings after the transaction were 1126333.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 15, 2026
- Filing date
- Oct 16, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
CSBR price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001628280-26-066091 Common Stock
- Transaction date
- Oct 15, 2026 Filed Oct 16, 2026, 04:45 PM · 1d delay
- Shares
- 69,794 sh $1.60 per share
- Estimated value
- $111k Computed from shares × price
- Holdings after
- 1,126,333 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
The Options vest and are exercisable over a twelve month period, with vesting to occur on January 31, 2017, April 30, 2017, July 31, 2017 and October 31, 2017, respectively.
0 other transactions
0 recent txs